ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMYT Amryt Pharma Plc

143.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 143.00 151.00 170.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Euronext Dublin Euronext Growth Dublin Notice (0797F)

11/07/2019 8:00am

UK Regulatory


TIDMAMYT

RNS Number : 0797F

Euronext Dublin

11 July 2019

 
            CORPORATE EVENT NOTICE:              Admission Notice 
                                                 AMRYT PHARMA PLC 
 
            LOCATION:                            Dublin 
 
            DATE:                                11th July 2019 
            MARKET:                              Euronext Growth Dublin 
 

ADMISSION NOTICE

Euronext Dublin approves the admission of the undermentioned security to trading on Euronext Growth Dublin.

AMRYT PHARMA PLC

45,802,881 Ordinary Shares GBP0.06

GB00BKB1MS30

Equity

This announcement has been issued through the Companies Announcement Service of

Euronext Dublin.

The present notice and the contents thereof are only provided for information purposes in order to facilitate the fair, orderly and efficient functioning of the market and is not a recommendation to engage in investment activities. The contents of this notice are provided "as is" based on information provided to the market operator without representation or warranty of any kind. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this notice shall form the basis of any contract. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext's subsidiaries shall depend solely on the applicable rules of the market operator.

The Euronext Markets comprise the markets operated by Euronext Amsterdam, Euronext Brussels, Euronext Dublin, Euronext Lisbon, Euronext Paris and Euronext UK Markets, referred to respectively as the Amsterdam, Brussels, Dublin, Lisbon, Paris and London markets, as relevant.

Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at https://www.euronext.com/terms-use.

(c) 2019 Euronext N.V. - All rights reserved

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISELIFETDLIILIA

(END) Dow Jones Newswires

July 11, 2019 03:00 ET (07:00 GMT)

1 Year Amryt Pharma Chart

1 Year Amryt Pharma Chart

1 Month Amryt Pharma Chart

1 Month Amryt Pharma Chart

Your Recent History

Delayed Upgrade Clock